08 October 2019 - 10 October 2019
Lyon, France
Scaling up synergies between the Global Fund and innovators to break down barriers to health innovation for the most vulnerable.
H7 Confluence, 70 Quai Perrache, 69002 Lyon at 4pm – 5.20pm
Co-hosts
- Drugs for Neglected Diseases initiative – DNDi
- Foundation for Innovative New Diagnostics – FIND
- Innovative Vector Control Consortium – IVCC
- International Partnership for Microbicides – IPM; Medicines for Malaria Venture – MMV
- PATH
- TB Alliance
Welcome – Stéphanie Seydoux, French Ambassador for Global Health
Opening session
- Michèle Boccoz, Director-General Envoy for Multilateral Affairs, WHO
- Catharina Boehme, CEO, FIND
- Marijke Wijnroks, Chief of Staff, Global Fund
Testimony from affected groups/communities – Aurélien Beaucamp, President, AIDES
Panel talks: Innovation upstream and downstream the Global Fund’s work – how to achieve optimal synergies – Moderator: Mark Chataway
Innovation upstream: from R&D to more powerful tools
- François Dabis, President, ANRS
- Renuka Gadde, Vice-President for Global Health, BD
- Tom McLean, Market Access Director, IVCC
- Zeda Rosenberg, CEO, IPM
Innovation downstream: from new health tools to impact
- E. Chitalu Chilufya, Minister of Health, Zambia
- Sanne Wendes, Chief of Staff, Unitaid
- Bernard Pécoul, Executive Director, DNDi
- Sherwin Charles, CEO and co-founder, Goodbye Malaria
Closing remarks: David Reddy, CEO, MMV
